Physicians' Academy for Cardiovascular Education

Covid-19

Overview of recent news and publications on COVID-19 and cardiovascular disease

Update on COVID-19 at AHA Scientific Sessions

10' education - Nov. 24, 2020 - Anthony Fauci, MD

No clinical benefit from suspending ACEi/ARBs in hospitalized patients with COVID-19

3' education - Sep. 7, 2020 - Prof. Renato D. Lopes, MD, PhD

Advantages of the digital 2020 ESC Congress

3' education - Sep. 1, 2020 - Prof. Barbara Casadei, MD

Huge impact of COVID-19 outbreak on patients with diseases that can normally be treated

3' education - Aug. 30, 2020 - Prof. Barbara Casadei, MD

Cardiac abnormalities in recovered COVID-19 patients

3' education - July 29, 2020 - Prof. Rudolf de Boer, MD, PhD

Increase in out-of-hospital cardiac arrest during the COVID-19 outbreak in Lombardy, Italy

3' education - May 8, 2020 - Enrico Baldi, MD

Venous thromboembolism in COVID-19 patients

5' education - May 6, 2020 - Prof. Saskia Middeldorp

Obesity as a risk factor for severity of COVID-19: multiple potential mechanisms

5' education - May 1, 2020 - Prof. Naveed Sattar, MD

COVID-19 associated thrombotic complications

5' education - Apr. 22, 2020 - Erik Klok, MD, PhD
Lecture 1 out of 3

COVID-19, ACE2 and RAASi - a scientific perspective

10' education - Apr. 19, 2020 - Prof. Jan Danser, PhD
Lecture 2 out of 3

A clinical perspective on COVID-19, ACE2 and RAAS inhibition

10' education - Apr. 18, 2020 - Prof. Murray Epstein, MD
Lecture (panel discussion) 3 out of 3

COVID-19, ACE2 and RAAS inhibition: What are the implications for practice?

10' education - Apr. 17, 2020 - Profs. John Deanfield, Jan Danser and Murray Epstein

CAPACITY COVID: a registry of CV variables in patients with COVID-19

3' education - Mar. 31, 2020 - Prof. Folkert Asselbergs, MD, PhD

Patients with HF hospitalized with COVID-19 at high risk for poor outcomes

Literature - Jan. 19, 2021 - Alvarez-Garcia J, et al. - J Am Coll Cardiol. 2020

Patients with HF admitted to hospital for COVID-19 had increased risk for in-hospital mortality and needed more often ICU care and intubation and mechanical ventilation compared to patients without HF.

Endothelial injury and dysfunction in COVID-19

Literature - Jan. 19, 2021 - Evans PC et al., - Cardiovasc Res. 2020

This position paper discusses the cause and consequences of endothelial injury and dysfunction in COVID-19.

Increased in-hospital mortality in COVID-19 patients with myocardial injury and echocardiographic abnormalities

Literature - Dec. 1, 2020 - Giustino G, et al. - J Am Coll Cardiol. 2020

A study of 305 hospitalized COVID-19 patients showed that approximately two-third of patients with evidence of myocardial injuries had echocardiographic abnormalities. In these patients, risk of in-hospital mortality was increased.

Update on COVID-19 at AHA Scientific Sessions

10' education - Nov. 24, 2020 - Anthony Fauci, MD
Anthony Fauci gives a presentation on COVID-19: Public health and scientific challenges.

AHA 2020 Anthony Fauci gives a presentation on COVID-19: Public health and scientific challenges.

COVID-19 and risk of HFpEF

News - Nov. 3, 2020

This viewpoint article in JAMA reviews the latest findings on the risk of heart failure, particularly HFpEF, in those who developed acute COVID-19 and those who have recovered from the illness.

Decrease in primary care visits, but increase in telemedicine during COVID-19 pandemic in USA

Literature - Oct. 13, 2020 - Alexander GC, et al. - JAMA Netw Open. 2020

Changes in the structure of primary care delivery, and differences in content of telemedicine visits vs. office-based visits were observed in the USA during the COVID-19 pandemic.

No clinical benefit from suspending ACEi/ARBs in hospitalized patients with COVID-19

3' education - Sep. 7, 2020 - Prof. Renato D. Lopes, MD, PhD
BRACE CORONA was a randomized trial that tested two strategies in hospitalized patients with COVID-19 who were on ACEi or ARBs: Temporarily suspending or continuing ACEi/ARBs. Prof. Lopes discusses the results.

ESC 2020 BRACE CORONA was a randomized trial that tested two strategies in hospitalized patients with COVID-19 who were on ACEi or ARBs: Temporarily suspending or continuing ACEi/ARBs. Prof. Lopes discusses the results.

Randomized trial on continuing versus suspending ACEi and ARBs in COVID-19

News - Sep. 1, 2020

ESC 2020 Suspension of ACEi/ARB therapy for 30 days did not impact the number of days alive and out of hospital at 30 days compared to continued use of these medications in COVID-19 patients.

Advantages of the digital 2020 ESC Congress

3' education - Sep. 1, 2020 - Prof. Barbara Casadei, MD
Although networking opportunities are poor during this year's ESC congress, there are plusses for a digital congress. Prof. Casadei lists some of them.

ESC 2020 Although networking opportunities are poor during this year's ESC congress, there are plusses for a digital congress. Prof. Casadei lists some of them.

Huge impact of COVID-19 outbreak on patients with diseases that can normally be treated

3' education - Aug. 30, 2020 - Prof. Barbara Casadei, MD
During the COVID-19 outbreak, some areas have seen an increase in excess mortality up to 40-50%, not due to COVID-19. Prof. Casadei strongly urgues that in the future physicians should save lives of patients they know how to save.

ESC 2020 During the COVID-19 outbreak, some areas have seen an increase in excess mortality up to 40-50%, not due to COVID-19. Prof. Casadei strongly urgues that in the future, physicians should save lives of patients they know how to save.

Cardiac abnormalities in recovered COVID-19 patients

3' education - July 29, 2020 - Prof. Rudolf de Boer, MD, PhD
Prof. De Boer discusses a recent paper in JAMA Cardiol on cardiac abnormalities detected by cardiovascular MRI in 100 patients who had proven COVID-19 around 2 months ago.

Prof. De Boer discusses a recent paper in JAMA Cardiol on cardiac abnormalities detected by cardiovascular MRI in 100 patients who had proven COVID-19 around 2 months ago.

Cardiac involvement and ongoing myocardial inflammation in recovered COVID-19 patients

Literature - July 28, 2020 - Puntmann VO et al., - JAMA Cardiol. 2020.

Cardiovascular MRI revealed cardiac involvement in 78% of patients and ongoing myocardial inflammation in 60% of patients in an unselected cohort of 100 patients who recently recovered from COVID-19.

Covid-19